The ROE as of September 2024 (TTM) for Assertio Holdings, Inc. (ASRT) is -231.03%

According to Assertio Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is -231.03%. This represents a change of 379.68% compared to the average of -48.16% of the last 4 quarters.

Assertio Holdings, Inc. (ASRT) Historical ROE (quarterly & annually)

How has ASRT ROE performed in the past?

The mean historical ROE of Assertio Holdings, Inc. over the last ten years is -68.56%. The current -231.03% ROE has changed 236.95% with respect to the historical average. Over the past ten years (40 quarters), ASRT's ROE was at its highest in in the March 2020 quarter at 49.06%. The ROE was at its lowest in in the December 2019 quarter at -332.35%.

Assertio Holdings, Inc. (ASRT) ROE by Quarter and Year

Discovering the peaks and valleys of Assertio Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Assertio Holdings, Inc. (ASRT) Average ROE

How has ASRT ROE performed in the past?

The current ROE of Assertio Holdings, Inc. (ASRT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Assertio Holdings, Inc. (ASRT) ROE vs. Peers

How is ASRT’s ROE compared to its peers?

Assertio Holdings, Inc.’s ROE is less than Agile Therapeutics, Inc. (104.04%), greater than Amneal Pharmaceuticals, Inc. (-1322.15%), greater than AcelRx Pharmaceuticals, Inc. (-48.62%), less than Lifecore Biomedical, Inc. (26.37%), greater than Ironwood Pharmaceuticals, Inc. (-2.78%), less than Neurocrine Biosciences, Inc. (14.86%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), less than Esperion Therapeutics, Inc. (26.20%), less than ANI Pharmaceuticals, Inc. (6.02%), less than Alkermes plc (22.66%), less than Dr. Reddy's Laboratories Limited (20.28%), less than Collegium Pharmaceutical, Inc. (49.14%), less than Pacira BioSciences, Inc. (7.32%), greater than Intra-Cellular Therapies, Inc. (-11.48%), greater than Catalent, Inc. (-26.99%), less than Amphastar Pharmaceuticals, Inc. (25.42%), less than Alvotech (86.54%), less than Eagle Pharmaceuticals, Inc. (4.41%), less than Evolus, Inc. (9.25%),

Build a custom stock screener for Assertio Holdings, Inc. (ASRT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Assertio Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Assertio Holdings, Inc. (ASRT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Assertio Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.